Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies [Phase 3]
A Phase 3 clinical trial comparing haploidentical hematopoietic stem cell transplantation from young non-first-degree donors versus older fi…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine [Phase 1]
Phase 1 open-label bioavailability study comparing pharmacokinetics of oral cladribine with intravenous cladribine. The study status is TERM…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. [Phase 1]
Arovella Therapeutics reports a Phase 1 study of ALA-101 in CD19-positive Non-Hodgkin lymphoma and leukemia; the trial is not yet recruiting…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft [Phase 1]
A Stanford-sponsored Phase 1 trial is evaluating reduced-intensity, allogeneic hematopoietic cell transplantation with a T-cell–depleted gra…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT) [NA]
This clinical trial update describes a study evaluating reduced-intensity conditioning with 200 cGy versus 400 cGy total body irradiation in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) [Phase 2]
This update notes that the BMT-06 study of intensity-modulated total marrow irradiation (IM-TMI) is a Phase 2 trial currently recruiting for…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
This update reports long-term follow-up of patients who participated in Children's Oncology Group studies; the trial is currently active but…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials [NA]
A clinical trial update describing efforts to improve adolescent and young adult self-reported data in ECOG-ACRIN trials, with trials curren…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies [Phase 1]
Phase 1 trial evaluating an anti-CD30 bispecific antibody (AATC) in relapsed/refractory CD30-positive hematologic malignancies; currently re…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]
Clinical trial update for Allo-QuadCAR01-T, an allogeneic CD19/CD20 CAR-T, in relapsed or refractory B-cell malignancies, currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy [NA]
A completed clinical trial evaluating exercise prehabilitation in older patients with hematological malignancies preparing for CAR-T cell im…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis [NA]
This clinical trial update describes evaluating a formalized care support program after an acute leukemia diagnosis; the study is not yet re…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia [NA]
This ClinicalTrials.gov entry describes the Emotion and Symptom-Focused Engagement Trial for individuals with acute leukemia, sponsored by t…
-
CLINICAL_TRIALS other · 2026-03-27Clinical Trial Update: The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias [Phase 1, Phase 2]
A Phase 1/2 clinical trial is assessing the safety and tolerability of LBS-007 in patients with relapsed or resistant acute leukemia and is …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Clonal Hematopoiesis of Immunological Significance
This is a clinical trial update about clonal hematopoiesis of immunological significance (CHIS) sponsored by Assistance Publique - Hôpitaux …
-
CLINICAL_TRIALS other · 2026-03-23Clinical Trial Update: Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study [Phase 2]
Clinical trial HALTAging-1 is a Phase 2 study targeting aging in survivors of blood cancers; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial update describes a new double epigenetic regimen being studied in relapsed or refractory acute myeloid leukemia, with the st…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: BY002 IIT Study in R/R Acute Leukemia [Phase 1]
Investigator-initiated phase 1 trial of BY002 in relapsed/refractory acute leukemia, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]
Phase 2 trial evaluating HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide is act…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
This clinical trial update outlines a natural history study to characterize drug metabolism phenotype in patients undergoing allogeneic hema…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating nivolumab and/or ipilimumab with or without azacitidine for myelodysplastic syndromes; currently active but not rec…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant [Phase 1]
A Phase 1 clinical trial evaluating Revumenib for acute leukemia in patients after allogeneic stem cell transplant; the study is currently r…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia [NA]
This clinical trial update describes a study evaluating a spiritual care intervention for adults diagnosed with acute leukemia. The trial is…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) [NA]
A hematology-focused clinical trial update for HEM-Profiling 2021, currently recruiting to explore chemogenomic profiling across multiple le…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Feasibility of a Multi-omics Platform for Hematological Malignancies [NA]
This clinical trial update assesses the feasibility of a multi-omics platform for hematological malignancies and is currently recruiting. It…